BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38126564)

  • 1. Possible role of ALDH1 and CD44 in lip carcinogenesis.
    Ortiz RC; Gois GG; Costa CA; Costa NL; Rodini CO
    J Appl Oral Sci; 2023; 31():e20230227. PubMed ID: 38126564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
    Custódio M; Pelissari C; Santana T; Trierveiler M
    Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1877-1883. PubMed ID: 29779037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of stem cell markers Nanog and Nestin in lip squamous cell carcinoma and actinic cheilitis.
    Scotti FM; Mitt VC; Vieira DS; Biz MT; Castro RG; Modolo F
    Oral Dis; 2018 Oct; 24(7):1209-1216. PubMed ID: 29761881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
    Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
    Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT-5A, but not matrix metalloproteinase 3 or beta-catenin protein, expression is related to early stages of lip carcinogenesis.
    Xavier FC; Rodini CO; Ramalho LM; Mantesso A; Nunes FD
    J Oral Pathol Med; 2009 Oct; 38(9):708-15. PubMed ID: 19473452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of ALDH1 and CD44 positivity for radiotherapy response and prognosis in early-stage glottic laryngeal squamous cell carcinoma.
    Surmelioglu O; Erdogan K; Dagkiran M; Ozdemir S; Tarkan O; Uguz A
    Pol J Pathol; 2022; 73(1):43-49. PubMed ID: 35848480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.
    Bianco BC; Scotti FM; Vieira DS; Biz MT; Castro RG; Modolo F
    Int J Exp Pathol; 2015 Oct; 96(5):311-8. PubMed ID: 26515234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 Immunoexpression in lip carcinogenesis.
    Xavier FC; Takiya CM; Reis SR; Ramalho LM
    J Mol Histol; 2009 Apr; 40(2):131-7. PubMed ID: 19526317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
    DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
    Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
    Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
    Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.
    Correa GT; Bernardes VF; de Sousa SF; Diniz MG; Salles JM; Souza RP; De-Paula AM; Gomez RS; Gomes CC
    Tumour Biol; 2015 Nov; 36(11):9059-66. PubMed ID: 26084614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of HLA-G, HLA-E and IL-10 expression in lip carcinogenesis.
    Gonçalves AS; Oliveira JP; Oliveira CF; Silva TA; Mendonça EF; Wastowski IJ; Batista AC
    Hum Immunol; 2016 Sep; 77(9):785-90. PubMed ID: 26723902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin Immunostaining in Biopsies as a Useful Biomarker of Early Invasion in Actinic Cheilitis and Differential Diagnosis Between Actinic Cheilitis and Lip Cancer: New Insights.
    Vageli D; Doukas PG; Zacharouli K; Kakanis V; Strataki M; Zioga A; Skoulakis C; Koukoulis G; Ioannou M
    Head Neck Pathol; 2023 Jun; 17(2):331-338. PubMed ID: 36303015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of DNA methyltransferases 1, 3a, and 3b in actinic cheilitis and lip squamous cell carcinomas.
    Daniel FI; Alves SR; Vieira DS; Biz MT; Daniel IW; Modolo F
    J Oral Pathol Med; 2016 Nov; 45(10):774-779. PubMed ID: 27159259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic and Clinicopathologic Features of Actinic Cheilitis and Lip Squamous Cell Carcinoma: a Brazilian Multicentre Study.
    Silva LVO; de Arruda JAA; Abreu LG; Ferreira RC; da Silva LP; Pelissari C; Silva RNF; Nóbrega KHS; de Andrade BAB; Romañach MJ; Agostini M; Nonaka CFW; Alves PM; Pontes HAR; Rivero LF; de Souza LB; Trierveiler M; Mendonça EF; Gomes APN; Martins MD; Andrade ESS; da Silveira MMF; Sobral APV; Mesquita RA
    Head Neck Pathol; 2020 Dec; 14(4):899-908. PubMed ID: 32077056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic features in actinic cheilitis by the comparison of grading dysplasia systems.
    Pilati S; Bianco BC; Vieira D; Modolo F
    Oral Dis; 2017 Mar; 23(2):219-224. PubMed ID: 27759902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.
    Jakob M; Sharaf K; Schirmer M; Leu M; Küffer S; Bertlich M; Ihler F; Haubner F; Canis M; Kitz J
    Strahlenther Onkol; 2021 Mar; 197(3):231-245. PubMed ID: 32588101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.